ArticleThe Lancet. Oncology2021

Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.

Jacob G Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.